Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HeroMD PRIME is a compounded prescription medication formulated as a daily chewing gum for the treatment of erectile dysfunction (ED). Developed by HeroMD, a men's telehealth platform operated by Cured Med, LLC, the formulation contains two FDA-approved phosphodiesterase type 5 (PDE5) inhibitors — tadalafil (5 mg) and vardenafil (5 mg) — along with the dietary supplements Vitamin D3 (cholecalciferol) and Vitamin K2 (menaquinone). Unlike on-demand ED treatments, HeroMD PRIME is designed for daily use to maintain consistent drug levels in the system, promoting spontaneous erectile function. It is prepared by licensed 503A compounding pharmacies and requires a prescription from a U.S.-licensed clinician.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HeroMD PRIME.